Skip to content

Clinical Study for Huber360 Core Muscle Strength Training Combined With Traditional Rehabilitation Therapy on Balance Function and Walking Ability of Stroke Patients

Clinical Study for Huber360 Core Muscle Strength Training Combined With Traditional Rehabilitation Therapy on Balance Function and Walking Ability of Stroke Patients

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR1900026444
Enrollment
Unknown
Registered
2019-10-10
Start date
2019-10-17
Completion date
Unknown
Last updated
2019-10-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Stroke

Interventions

experimental group:Huber 360 Core Strength Training
control group:conventional therapy

Sponsors

Beijing Tsinghua Changgung Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Diagnosis met the criteria of the 4th National Academic Conference on Cerebrovascular Diseases in 1995. The first diagnosis was initial stroke (cerebral infarction or cerebral hemorrhage), which was confirmed by CT or MIR. The lesion was located in the cerebellum or brainstem. The onset time was from 1 month to 3 months, and the age was 25 to 75 years old. Those who were conscious and able to cooperate normally were able to reach the first level of standing balance and could be assisted. Can stand. The life signs are stable and can tolerate Huber 360 core strength training; no history of brain trauma, encephalitis, tuberculosis meningitis and other brain parenchymal and central nervous system involvement; good compliance with the observation and evaluation of researchers; with the consent of patients or family members and signed informed consent.

Exclusion criteria

Exclusion criteria: Patients with progressive stroke; transient ischemic attack; patients with cognitive impairment or psychiatric symptoms, dementia and various aphasia who could not cooperate with rehabilitation training; patients with severe spasm or limited range of joint movement on the paralyzed limbs; patients with severe infection or complications (heart, lung, Liver, kidney).

Design outcomes

Primary

MeasureTime frame
Holden walking function rating scale;

Secondary

MeasureTime frame
Fugl-Meyer Assessment;Bathel Index;Berg Balance Scale;10 meters walking time;VO2max;

Countries

China

Contacts

Public ContactQuan Xu

Beijing Tsinghua Changgung Hospital

xuquanspecial@163.com+86 13488716153

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026